Beijing Jyton & Kannel Medical Technology

Beijing Jyton & Kannel Medical Technology Co., Ltd. is a leading Chinese Contract Research Organization (CRO) specializing in the medical device and in vitro diagnostic (IVD) sectors. As a wholly-owned subsidiary of Tigermed, the company provides comprehensive services including NMPA registration, clinical trial management, and regulatory consulting to both domestic and international manufacturers. Formed through the integration of two established firms, Jyton and Kannel, it leverages deep expertise in Chinese regulations to facilitate market entry and compliance. The company has supported the approval of a wide range of innovative medical technologies, from high-risk implants to digital health solutions. Its service portfolio also encompasses quality management system (QMS) auditing and post-market surveillance.